(19)
(11) EP 2 271 934 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
18.09.2013 Bulletin 2013/38

(45) Mention of the grant of the patent:
07.08.2013 Bulletin 2013/32

(21) Application number: 09734270.3

(22) Date of filing: 21.04.2009
(51) International Patent Classification (IPC): 
G01N 33/68(2006.01)
(86) International application number:
PCT/GB2009/050404
(87) International publication number:
WO 2009/130505 (29.10.2009 Gazette 2009/44)

(54)

DIAGNOSIS AND/OR PROGNOSIS OF RENAL DYSFUNCTION

DIAGNOSE UND/ODER PROGNOSE VON NIERENDYSFUNKTION

DIAGNOSTIC ET/OU PRONOSTIC DE DYSFONCTION RÉNALE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

(30) Priority: 21.04.2008 GB 0807214

(43) Date of publication of application:
12.01.2011 Bulletin 2011/02

(73) Proprietors:
  • Belfast Health And Social Care Trust
    Belfast BT9 7AB (GB)
  • The Queen's University of Belfast
    Belfast BT7 1NN Northern Ireland (GB)

(72) Inventors:
  • MCBRIDE, William Thomas
    Lisburn Antrim BT27 5QE (GB)
  • ARMSTRONG, Marilyn
    Belfast Antrim BT12 6BA (GB)

(74) Representative: Thomson, Craig Richard 
Murgitroyd & Company Scotland House 165-169 Scotland Street
Glasgow G5 8PL
Glasgow G5 8PL (GB)


(56) References cited: : 
RU-C1- 2 302 633
 US-B1- 7 141 382
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).